Bergen, Norway

Crina Tiron

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bergenbio Asa. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Crina Tiron. Retrieved from https://idiyas.com/inventor/crina-tiron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Crina Tiron: Innovator in Cancer Research

Introduction

Crina Tiron is a prominent inventor based in Bergen, Norway. She has made significant contributions to the field of cancer research, particularly in the detection and treatment of cancer through innovative methods.

Latest Patents

Crina Tiron holds a patent titled "Methods of detecting Akt3 and administering Ax1 inhibitor." This patent discloses the use of Akt3 as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject. It also details the use of Akt3 inhibitors to treat cancer. Various methods for detecting the occurrence of EMT in a subject by measuring Akt3 expression and/or activity are also included in her patent. She has 1 patent to her name.

Career Highlights

Crina Tiron is associated with Bergenbio ASA, a company that focuses on developing innovative cancer therapies. Her work has been instrumental in advancing the understanding of cancer biomarkers and treatment options.

Collaborations

Crina collaborates with Jim Lorens, who is also involved in cancer research. Their partnership has contributed to the development of new methodologies in the field.

Conclusion

Crina Tiron is a dedicated inventor whose work in cancer research is paving the way for new diagnostic and therapeutic approaches. Her innovative methods and collaborations are making a significant impact in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…